Chan Gerald 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Chan Gerald
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-01-01$30.62/sh+27,600$845,112→ 27,600 totalExercise: $30.62Exp: 2029-12-31→ Common Stock (27,600 underlying)
Footnotes (1)
- [F1]This option was granted January 1, 2020. The option vests quarterly over one year on the last day of each quarter from grant date.